Tips on possible risks of using Brivaracetam
Brivaracetam/Brivaracetam is a drug used to treat epilepsy. It belongs to anti-epileptic drugs (AEDs) and is particularly suitable for partial seizures (including secondary generalized seizures). Brivaracetam reduces the occurrence of epileptic seizures by acting on certain neuroreceptors in the brain, regulating the electrical activity of neurons. Although the efficacy of brivaracetam has been clinically proven, you still need to be aware of its possible risks and side effects when using this drug.

Common side effects of brivaracetam include drowsiness, headache, fatigue, nausea, and dizziness. These side effects are usually mild and may improve as the patient adjusts to the medication. However, some patients may experience more serious adverse reactions, such as mood changes, depressive symptoms, or behavioral abnormalities (including aggressive behavior and suicidal tendencies). Therefore, patients need to be closely monitored for the occurrence of these symptoms while taking brivaracetam, especially during the initial stages of treatment or during dose adjustments.
Although rare, brivaracetam may also cause allergic reactions. Allergy symptoms include rash, difficulty breathing, facial swelling, etc. If these symptoms occur, stop taking brivaracetam immediately and seek medical help.
Interactions between Brivaracetam and other drugs are also issues that require special attention when taking the drug.布瓦西坦的代谢主要通过肝脏中的酶系统进行,特别是CYP2C19和CYP3A4。 Therefore, when used together with inhibitors or inducers of these enzymes, the plasma concentration of brivaracetam may be affected, thereby affecting the efficacy or increasing the risk of adverse reactions. For example, when brivaracetam is combined with certain antiepileptic drugs (such as carbamazepine), the risk of side effects from the drugs may be increased.
Sudden discontinuation of brivaracetam may increase the frequency of seizures and may even cause severe seizures. Therefore, when it is necessary to discontinue medication, patients should gradually reduce the dose under the guidance of a doctor to reduce the risk of recurrence.
Reference materials:https://www.briviact.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)